|
Goldman
Philanthropic Partnerships and Memorial Sloan-Kettering Create
Innovative Cancer Research Partnership
FOR
IMMEDIATE RELEASE
June
10, 2003
New
York, NY -- Goldman Philanthropic Partnerships (GPP) and
Memorial Sloan-Kettering Cancer Center (MSKCC) have joined
together to foster innovative cancer research.
The non-profit Goldman Philanthropic Partnerships
inspires pioneering medical research by creating partnerships
between leading research institutions, inventive researchers,
nonprofit organizations and dedicated philanthropists.
This specific partnership, known as the MSKCC Inspired
Venture in Innovative Cancer Research, allows GPP donors to
target their funding to and be involved with one or more
specific projects at MSKCC that could provide new advances in
treating cancer.
To
initiate the partnership, GPP donors are co-funding breast
cancer research that involves adding whole botanical medicines
to current chemotherapy and immunotherapy regimens to show how
these safe and widely used compounds can improve the outcomes
for patients without any additional side effects.
Dr.
Barrie Cassileth,
Chief, Integrative Medicine Service, describes the project as
“an exciting and innovative endeavor all around, and one
with the potential to produce effective therapies with minimal
or no toxicity.”
She
adds,
“We are grateful that GPP and its donors understand
the critical nature of funding this type of research at this
stage of investigation."
“The
integrative medicine program at Memorial Sloan-Kettering
Cancer Center is an ideal GPP Partner,” said GPP CEO Dr.
Bruce E. Bloom. “It has an international reputation,
creative researchers with great new ideas and well established
successes, and a collaborative environment that will help
harness the knowledge of a wide variety of scientists.
Our science advisors thought this botanical medicine
research was of critical importance, and very well designed.
Partnership with MSKCC offers our donors a chance to
personally travel down the path to scientific discovery with
some of the best researchers in the world."
The
involvement of GPP brings business accountability to the
research process. “We produce an approved business plan
committed to by every researcher, with specific aims and goals
to be achieved and evaluated every 90 days, and continue
research funding only as the researchers achieve stated aims
and goals – or reasonably modified alternatives” said Dr.
Bloom. “We
provide progress reports to our donors every 90 days and
broadly report results of every research project to promote
the potential benefits to patients.
Through our new partnership with MSKCC, we will push
the research envelope, bring greater donor involvement to the
research process, and help to insure the results reach
patients quickly."
The
Goldman Philanthropic Partnerships was co-founded by George
and Judith Goldman, who created the nonprofit organization
as a way of giving back after Judith’s successful battle
against multiple myeloma, a blood cancer that has been in
remission since 1990. Today,
the foundation continues to inspire new advances in medicine
by seeking out, validating, co-funding, monitoring and
reporting to donors the innovative research that may cure
catastrophic diseases, such as cancer or diabetes.
Contact:
Dr. Bruce E. Bloom, CEO (847) 948-5512 (bruce@goldmanpartnerships.org) |
